Cube Pharmaceuticals announced that the 8th meeting of the sixth board of directors of the company deliberated and passed two proposals: one passed the “Report for the Third Quarter of 2026”; the other was to agree to elect Ji Tiecheng as the vice chairman of the sixth board of directors of the company. The term of office begins on the date of review and approval by the board of directors and ends on the date the term of the sixth board of directors expires. Eight directors should attend this meeting, and eight actually attend. The procedure for calling and holding the meeting complies with relevant regulations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.